Supplementary figures
Figure S1 -resistance generation in vitro. 
Supplementary tables
Table S1 -whole genome sequencing for L. donovani clones resistant to compound 1. Table S2 -whole genome sequencing for T. cruzi clones resistant to compound 1. Table S3 -compounds 1 and 2 in complex III assays with WT and resistant cell lysates. Table S5 -Assessment of compound potency against wild-type and resistant L. donovani cell lines in intra-macrophage assays. The potency of compounds 1 and 2 were assessed against WT parasites and also resistant clones generated by exposure to compounds 1 and 2. Compound DDD01012232, an established divalent cation chelator [58] , was also assessed as a negative control. Cell lines demonstrating resistance or crossresistance relative to wild-type are highlighted in blue while those demonstrating hypersensitivity are highlighted in grey. Fold-changes in sensitivity compared to wild-type are in parentheses.
Data represents the mean ± SD of at least two technical replicates. (6) Compound 2 0.4 0.03 (13) 4.4 (11) 
